A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects

Clinical trial NCT06408285 · COMPLETED

Trial details

NCT number: NCT06408285
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2024-05-22
Primary completion: 2024-08-19
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.